Transport of xenobiotics across the blood-brain barrier

News in Physiological Sciences

Volumn 17, Issue 6, 2002, Pages 231-234

  Hagenbuch, Bruno ^a   Gao, Bo ^a   Meier, Peter J ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMPRENAVIR; CARRIER PROTEIN; CYANOGINOSIN; CYCLOSPORIN; DEXAMETHASONE; DIGOXIN; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; ESTRADIOL 17 GLUCURONIDE; ESTRONE SULFATE; FEXOFENADINE; INDINAVIR; IVERMECTIN; LEUKOTRIENE C4; LIOTHYRONINE; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; NELFINAVIR; ORGANIC ANION TRANSPORTER; PACLITAXEL; PHOSPHATIDYLCHOLINE; PRASTERONE SULFATE; ROCURONIUM; SAQUINAVIR; THYROXINE; TSUKUBAENOLIDE; UNINDEXED DRUG; VALSPODAR; VINBLASTINE; XENOBIOTIC AGENT;

ANIMAL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN PROTECTION; DRUG TARGETING; DRUG TRANSPORT; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MULTIDRUG RESISTANCE; NONHUMAN; PHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

ANIMALS; BLOOD-BRAIN BARRIER; CARRIER PROTEINS; HUMANS; XENOBIOTICS;

EID: 0036916855     PISSN: 08861714     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Asaba H, Hosoya K, Takanaga H, Ohtsuki S, Tamura E, Takizawa T, and Terasaki T. Blood-brain barrier is involved in the efflux transport of a neuroactive steroid, dehydroepiandrosterone sulfate, via organic anion transporting polypeptide 2. J Neurochem 75: 1907-1916, 2000.
2. Ayrton A and Morgan P. Role of transport proteins in drug absorption, distribution and excretion. Xenobiotica 31: 469-497, 2001.
3. Beaulieu E, Demeule M, Ghitescu L, and Beliveau R. P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain. Biochem J 326: 539-544, 1997.
4. Borst P, Evers R, Kool M, and Wijnholds J. The multidrug resistance protein family. Biochim Biophys Acta 1461: 347-357, 1999.
5. 2,5]-enkephalin at the murine blood-brain barrier by in situ perfusion. Neurosci Lett 301: 155-158, 2001.
6. Gao B, Hagenbuch B, Kullak-Ublick GA, Benke D, Aguzzi A, and Meier PJ. Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. J Pharmacol Exp Ther 294: 73-79, 2000.
7. Gao B and Meier PJ. Organic anion transport across the choroid plexus. Microsc Res Tech 52: 60-64, 2001.
8. Gao B, Stieger B, Noè B, Fritschy JM, and Meier PJ. Localization of the organic anion transporting polypeptide 2 (Oatp2) in capillary endothelium and choroid plexus epithelium of rat brain. J Histochem Cytochem 47: 1255-1264, 1999.
9. Juliano RL and Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455: 152-162, 1976.
10. Kartenbeck J, Leuschner U, Mayer R, and Keppler D. Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology 23: 1061-1066, 1996.
11. König J, Nies AT, Cui Y, Leier I, and Keppler D. Conjugate export pumps of the multidrug resistance protein (MRP) family: Localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta 1461: 377-394, 1999.
12. Mayer U, Wagenaar E, Dorobek B, Beijnen JH, Borst P, and Schinkel AH. Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833. J Clin Invest 100: 2430-2436, 1997.
13. Meier PJ, Eckhardt U, Schroeder A, Hagenbuch B, and Stieger B. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver. Hepatology 26: 1667-1677, 1997.
14. Miller DS, Nobmann SN, Gutmann H, Toeroek M, Drewe J, and Fricker G. Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. Mol Pharmacol 58: 1357-1367, 2000.
15. Pardridge WM. Drug and gene targeting to the brain with molecular Trojan horses. Nat Rev Drug Disc 1: 131-139, 2002.
16. Rappa G, Finch RA, Sartorelli AC, and Lorico A. New insights into the biology and pharmacology of the multidrug resistance protein (MRP) from gene knockout models. Biochem Pharmacol 58: 557-562, 1999.
17. Schinkel AH. The physiological function of drug-transporting P-glycoproteins. Semin Cancer Biol 8: 161-170, 1997.
18. Schinkel AH, Smit JJM, Vantellingen O, Beijnen JH, Wagenaar E, Vandeemter L, Mol CAAM, Vandervalk MA, Robanusmaandag EC, Teriele HPJ, Berns AJM, and Borst P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77: 491-502, 1994.
19. Sugiyama D, Kusuhara H, Shitara Y, Abe T, Meier PJ, Sekine T, Endou H, Suzuki H, and Sugiyama Y. Characterization of the efflux transport of 17β-estradiol-D-17β-glucuronide from the brain across the blood-brain barrier. J Pharmacol Exp Ther 298: 316-322, 2001.
20. Tamai I, Nezu J, Uchino H, Sai Y, Oku A, Shimane M, and Tsuji A. Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem Biophys Res Commun 273: 251-260, 2000.